Monthly Archives: September 2008

MSK team finds rare new mutation

Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York have found a rare mutation in some GIST tumors. In a series of 61 patients with wild-type GIST, they found that three of them (5%) had mutations in a gene called BRAF. This same mutation, a “V600E” mutation in exon 15 of the BRAF gene, occurs frequently in melanoma. They also found the same mutation in one of 28 GIST patients that were resistant to Gleevec.

By |2019-12-30T10:54:23-05:00September 11th, 2008|Research|

Gleevec Receives FDA Priority Review

Gleevec receives FDA priority review as first therapy to reduce recurrence of GI stromal tumors after surgery East Hanover, August 27, 2008 — Novartis announced today that Gleevec® (imatinib mesylate) tablets has been granted priority [...]

By |2019-12-30T10:57:35-05:00September 2nd, 2008|Gleevec|
Go to Top